Literature DB >> 27131635

Intramedullary ependymoma: Microsurgical resection technique.

L Giammattei1, N Penet2, F Parker2, M Messerer2.   

Abstract

Spinal ependymomas are predominantly slow-growing lesions constituting approximately 30-88% of primary spinal intramedullary tumors. They usually present as circumscribed lesions, with regular margins and a clear surgical plane. Gross-total resection is often feasible and potentially curative but neurosurgeons should keep in mind that the ultimate goal of surgery is the preservation of spinal cord function. We present the surgical technique to safely resect an intramedullary ependymoma using a posterior median sulcus approach. A brief description of current management of this pathology is also presented.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Dorsal mielotomy; Intraoperative monitoring; Neuromonitoring; Sillon médullaire dorsal; Spinal ependymomas; Spinal intramedullary tumors; Tumeur intramédullaire; Épendymome

Mesh:

Year:  2016        PMID: 27131635     DOI: 10.1016/j.neuchi.2016.01.002

Source DB:  PubMed          Journal:  Neurochirurgie        ISSN: 0028-3770            Impact factor:   1.553


  3 in total

1.  Intramedullary clear cell ependymoma of the lower thoracic spinal cord: report of a new case.

Authors:  Jesus Rocha-Maguey; Jesus Salvador Velarde-Felix; Myriam Cabrera-Lopez; Jaime Moya-Nuñez; Edgar Fragosa-Sanchez
Journal:  Surg Neurol Int       Date:  2020-12-11

2.  Magnetic resonance imaging indicators for neurological outcome after surgery in patients with intramedullary spinal ependymomas.

Authors:  Yongqiang Ma; Bofeng Bai; Xihai Zhao; Lixue Wang; Benqi Zhao; Yi Guo; Hongfang Yin; Xiaofei Zhang; Zhuozhao Zheng
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

3.  Microsurgical Resection of Brain Stem Ependymoma: 2-Dimensional Operative Video.

Authors:  Mirza Pojskić; Vincent Nguyen; Goran Lakičević; Kenan I Arnautović
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-06-01       Impact factor: 2.703

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.